http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=32465 E. Vilar Sanchez,et al. ASCO Annual Meeting 2009;
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models Yan Luo, Yanping Luo, et al. Clin Cancer Res 2007;13:2728-2737
A novel poly(ADP-ribose) polymerase inhibitor, ABT-888,radiosensitizes malignant human cell lines under hypoxia Stanley K. Liu,Carla Coackley,et al. Radiotherapy and Oncology 2008;88:258–268
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.